We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$166M
AUM Growth
+$4.72M
Cap. Flow
+$4.91M
Cap. Flow %
2.96%
Top 10 Hldgs %
72.14%
Holding
622
New
62
Increased
177
Reduced
49
Closed
35

Top Buys

Rank Stock Value
1
ATRC icon
AtriCure
ATRC
+$1.4M
2
NEO icon
NeoGenomics
NEO
+$1.27M
3
CNTA
Centessa Pharmaceuticals
CNTA
+$882K
4
ATEC icon
Alphatec Holdings
ATEC
+$582K
5
TRV icon
Travelers Companies
TRV
+$549K

Top Sells

Rank Stock Value
1
MODN
MODEL N, INC.
MODN
+$1.03M
2
TELA icon
TELA Bio
TELA
+$980K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$535K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$319K
5
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$82.3K

Sector Composition

Rank Sector Weight
1 Healthcare 10.57%
2 Financials 4.94%
3 Technology 3.85%
4 Industrials 1.42%
5 Consumer Staples 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTNR
551
DELISTED
Vertex Energy, Inc
VTNR
$326 ﹤0.01%
345
– –
FLG
552
Flagstar Bank National Association
FLG
$5.74B
$323 ﹤0.01%
33
– –
TSVT
553
DELISTED
2seventy bio
TSVT
$293 ﹤0.01%
76
– –
SLVM icon
554
Sylvamo
SLVM
$1.5B
$281 ﹤0.01%
4
– –
ADAP
555
DELISTED
Adaptimmune Therapeutics
ADAP
$280 ﹤0.01%
287
– –
UAA icon
556
Under Armour
UAA
$3.02B
$280 ﹤0.01%
42
– –
UA icon
557
Under Armour Class C
UA
$2.95B
$274 ﹤0.01%
42
– –
IBRX icon
558
ImmunityBio
IBRX
$7.32B
$253 ﹤0.01%
+40
New +$264
AVGR
559
DELISTED
Avinger, Inc. Common Stock
AVGR
$236 ﹤0.01%
127
– –
APTO
560
DELISTED
Aptose Biosciences, Inc.
APTO
$228 ﹤0.01%
10
– –
BLUE
561
DELISTED
bluebird bio
BLUE
$226 ﹤0.01%
12
– –
BHF icon
562
Brighthouse Financial
BHF
$3.63B
$217 ﹤0.01%
+5
New +$231
VMBS icon
563
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.5B
$197 ﹤0.01%
4
– –
PRLD icon
564
Prelude Therapeutics
PRLD
$310M
$191 ﹤0.01%
50
– –
WW
565
DELISTED
WW International
WW
$187 ﹤0.01%
160
– –
ARAY icon
566
Accuray
ARAY
$26.8M
$182 ﹤0.01%
100
– –
BGFV
567
DELISTED
Big 5 Sporting Goods
BGFV
$169 ﹤0.01%
+57
New +$188
USIG icon
568
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$168 ﹤0.01%
3
– –
NKLA
569
DELISTED
Nikola Corporation Common Stock
NKLA
$164 ﹤0.01%
20
– –
KD icon
570
Kyndryl
KD
$2.81B
$158 ﹤0.01%
6
+4
+200% +$96
ICU icon
571
SeaStar Medical
ICU
$14.3M
$152 ﹤0.01%
2
-2
-50% -$214
AQST icon
572
Aquestive Therapeutics
AQST
$468M
$130 ﹤0.01%
+50
New +$167
LQDA icon
573
Liquidia Corp
LQDA
$7.51B
$120 ﹤0.01%
+10
New +$133
XFOR icon
574
X4 Pharmaceuticals
XFOR
$372M
$104 ﹤0.01%
+6
New +$196
BIL icon
575
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
$100 ﹤0.01%
1
– –
21 22
23
24 25

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, HighMark Wealth Management held 622 positions worth $166M, up 2.9% from $161M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighMark Wealth Management's Q2 2024 filing shows 62 new, 177 increased, 49 reduced and 35 closed positions. Its largest new stake was Centessa Pharmaceuticals: 93,000 shares worth $840K. The largest sale was MODEL N, INC., an estimated $1.03M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.1% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q2 2024 buy was Centessa Pharmaceuticals: 93,000 shares worth $840K.
  • HighMark Wealth Management added most to AtriCure in Q2 2024, an estimated $1.4M increase.
  • HighMark Wealth Management's biggest Q2 2024 reduction was TELA Bio, cutting an estimated $980K.
  • HighMark Wealth Management fully exited MODEL N, INC. in Q2 2024, selling an estimated $1.03M.
  • HighMark Wealth Management's ten largest holdings make up 72% of its $166M portfolio in Q2 2024.
  • HighMark Wealth Management opened 62 new positions and closed 35 in Q2 2024.
  • HighMark Wealth Management's portfolio value rose 2.9% quarter-over-quarter to $166M.

Based on HighMark Wealth Management's 13F filing for Q2 2024, filed 29 Jul 2024.